We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.05B
AUM Growth
+$527M
(+21%)
Cap. Flow
+$482M
Cap. Flow
% of AUM
15.81%
Top 10 Holdings %
Top 10 Hldgs %
28.17%
Holding
230
New
83
Increased
48
Reduced
47
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$73.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.4M |
| 3 |
Amazon
AMZN
|
+$65.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$61.2M |
| 5 |
Mastercard
MA
|
+$61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$65M |
| 2 |
PayPal
PYPL
|
+$52M |
| 3 |
eBay
EBAY
|
+$48.4M |
| 4 |
NXP Semiconductors
NXPI
|
+$42.9M |
| 5 |
Qorvo
QRVO
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.94% |
| 2 | Technology | 31.58% |
| 3 | Communication Services | 6.58% |
| 4 | Consumer Discretionary | 4.22% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Dell
DELL
$302B
| $3.21M | 0.11% |
+93,568
| New | +$2.92M |
|
|
PVLA
152
Palvella Therapeutics
PVLA
$2.18B
| $3.17M | 0.1% |
19,159
-1,858
| -9% | -$423K |
|
153
Surgery Partners
SGRY
$2.05B
| $3.17M | 0.1% |
+144,837
| New | +$2.57M |
|
154
DexCom
DXCM
$32.8B
| $3.16M | 0.1% |
30,644
-21,740
| -42% | -$2.27M |
|
155
HealthEquity
HQY
$8.78B
| $3.13M | 0.1% |
61,006
+54,906
| +900% | +$3.02M |
|
156
BellRing Brands
BRBR
$1.48B
| $3.05M | 0.1% |
+147,234
| New | +$2.9M |
|
157
BioCryst Pharmaceuticals
BCRX
$2.29B
| $2.98M | 0.1% |
868,708
-722,133
| -45% | -$3.09M |
|
|
MKTWW
158
DELISTED
MarketWise, Inc. Warrant
MKTWW
| $2.97M | 0.1% |
+2,004,385
| New | +$2.89M |
|
159
JFrog
FROG
$10.4B
| $2.54M | 0.08% |
+30,000
| New | +$2.23M |
|
|
MYOK
160
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.28M | 0.07% |
16,736
-97,303
| -85% | -$10.3M |
|
|
RAPT
161
DELISTED
RAPT Therapeutics
RAPT
| $2.17M | 0.07% |
+8,413
| New | +$1.87M |
|
162
QuidelOrtho
QDEL
$1.2B
| $2.12M | 0.07% |
9,645
-33,585
| -78% | -$7.49M |
|
|
P
163
Everpure Inc
P
$27.9B
| $2.1M | 0.07% |
136,529
-341,732
| -71% | -$5.59M |
|
164
Immatics
IMTX
$1.28B
| $1.98M | 0.06% |
+186,591
| New | +$1.97M |
|
165
Prothena Corp
PRTA
$444M
| $1.77M | 0.06% |
177,084
-423,694
| -71% | -$5.1M |
|
166
Arcturus Therapeutics
ARCT
$177M
| $1.67M | 0.05% |
39,016
-109,067
| -74% | -$5.41M |
|
167
Herbalife
HLF
$1.33B
| $1.52M | 0.05% |
+32,669
| New | +$1.6M |
|
|
LONA
168
LeonaBio Inc
LONA
$72M
| $1.34M | 0.04% |
+7,252
| New | +$1.21M |
|
|
CD
169
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $1.14M | 0.04% |
+70,000
| New | +$1.14M |
|
170
Abeona Therapeutics
ABEO
$389M
| $1.1M | 0.04% |
43,256
-12,978
| -23% | -$818K |
|
|
ACCD
171
DELISTED
Accolade Inc
ACCD
| $1.06M | 0.03% |
+27,375
| New | +$944K |
|
172
Revolution Medicines
RVMD
$41.1B
| $971K | 0.03% |
+27,911
| New | +$773K |
|
|
FUSN
173
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $915K | 0.03% |
76,093
-43,907
| -37% | -$600K |
|
|
PAND
174
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $861K | 0.03% |
+75,101
| New | +$1.28M |
|
|
ORTX
175
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $686K | 0.02% |
16,691
-12,534
| -43% | -$648K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Woodline Partners held 230 positions worth $3.05B, up 21% from $2.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Woodline Partners deployed $482M of net new capital in Q3 2020, opening 83 new positions and adding to 48 existing holdings. Its largest new stake was Microchip Technology: 1,413,308 shares worth $72.6M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Intel, an estimated $65M trimmed.
- Woodline Partners's largest Q3 2020 buy was Microchip Technology: 1,413,308 shares worth $72.6M.
- Woodline Partners added most to Johnson & Johnson in Q3 2020, an estimated $61.2M increase.
- Woodline Partners's biggest Q3 2020 reduction was Intel, cutting an estimated $65M.
- Woodline Partners fully exited PayPal in Q3 2020, selling an estimated $52M.
- Woodline Partners's ten largest holdings make up 28% of its $3.05B portfolio in Q3 2020.
- Woodline Partners opened 83 new positions and closed 52 in Q3 2020.
- Woodline Partners's portfolio value rose 21% quarter-over-quarter to $3.05B.
Based on Woodline Partners's 13F filing for Q3 2020, filed 16 Nov 2020.